Weight-loss guide
Tirzepatide starting dose: what the label prints
The Zepbound label says the recommended starting dosage is 2.5 mg injected subcutaneously once weekly for 4 weeks. That dose is for treatment initiation and is not approved as a maintenance dosage.
What the label prints
| Zepbound label (Section 2.1) | Plain version |
|---|---|
| “The recommended starting dosage of ZEPBOUND for all indications is 2.5 mg injected subcutaneously once weekly for 4 weeks.” | The label start is 2.5 mg, once a week, for 4 weeks. |
| “The 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage.” | The first dose is a starting step, not the dose you stay on. |
A clinician sets any dose and any change to it. A prescription is not automatic, and the clinician can say no. The Mounjaro label was not opened for this page.
Related: tirzepatide, semaglutide vs tirzepatide.
References
Opened 2026-10-16.
- DailyMed: Zepbound (tirzepatide) injection. Section 2.1, recommended starting dosage.
About Mendoxa
- Mendoxa serves 49 U.S. states. Not available in California.
- Licensed clinicians in the LocumTele network review every intake. The clinician can say no.
- When a prescription is issued, Rush Pharmacy fulfills it.
- A compounded medicine is not an FDA-approved finished product.
- The price is shown in the intake, not on this page.